A Q-Probes Study Involving Utilization of Free Prostate-Specific Antigen, Factor V Leiden, and Hepatitis A Serology Tests.
Context.--Managing the utilization of laboratory tests is an important quality improvement activity that adds value to health care. Objective.--To examine utilization of 3 laboratory tests and identify factors that impact performance. Design.--Test utilization performance was evaluated by determinin...
| Published in: | Archives of Pathology & Laboratory Medicine Vol. 143; no. 2; pp. 151 - 157 |
|---|---|
| Main Authors: | , , , |
| Format: | research tables/charts Journal Article |
| Published: |
College of American Pathologists
Feb2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134272555&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134272555 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00039985 1FS jtl: Archives of Pathology & Laboratory Medicine issn: 00039985 maglogo: N pubinfo: dt: Feb2019 vid: 143 iid: 2 pid: 2550 pub: College of American Pathologists place: Northfield, Illinois artinfo: ui: 134272555 134272555 134272555 10.5858/arpa.2018-0010-CP 134272555 ppf: 151 ppct: 6 formats: fmt: @attributes: type: P tig: atl: A Q-Probes Study Involving Utilization of Free Prostate-Specific Antigen, Factor V Leiden, and Hepatitis A Serology Tests. aug: au: Schifman, Ron B. Perrotta, Peter L. Souers, Rhona Blond, Barbara J. affil: Pathology and Laboratory Medicine, Southern Arizona VA Healthcare System, and the Department of Pathology, University of Arizona, Tucson sug: subj: Prostate-Specific Antigen Blood Factor V Leiden Blood Hepatitis A Diagnosis Serology Proficiency Testing, Laboratory Utilization Human Antibodies, Viral Mutation Diagnostic Errors Risk Factors ab: Context.--Managing the utilization of laboratory tests is an important quality improvement activity that adds value to health care. Objective.--To examine utilization of 3 laboratory tests and identify factors that impact performance. Design.--Test utilization performance was evaluated by determining the frequency with which appropriate preconditions for testing were met. This included 30 testing episodes each involving (1) free prostate-specific antigen (PSA) when total PSA was within an appropriate interpretable range, (2) total anti--hepatitis A virus antibody when previous anti--hepatitis A virus antibody results were either negative or not done, and (3) factor V Leiden mutation when a previous result was not already available. Participants also provided information regarding some of their utilization policies and procedures for these 3 tests. Results.--The overall frequency with which testing criteria were met was 20.6% (163 of 790), 91.5% (649 of 709), and 95.2% (799 of 839) for free PSA, anti-- hepatitis A virus antibody, and factor V Leiden, respectively. Utilization review was infrequent and done by 20.7% (6 of 29) of participants for factor V Leiden, 3.6% (1 of 28) for anti--hepatitis A virus antibody, and 3.6% (1 of 28) for free PSA. No practice or demographic characteristics were significantly associated with utilization performance for any test. Conclusions.--Utilization review was infrequent for the 3 tests examined. Variable amounts of unnecessary testing were observed for all tests, most frequently for free PSA, for which reporting results carried the added risk of diagnostic error from misinterpretation of results. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|